Envoy Medical
COCH
94 hedge funds and large institutions have $361M invested in Envoy Medical in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 9 closing their positions.
229% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 7
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
8% more capital invested
Capital invested by funds: $335M → $361M (+$26.1M)
7% more funds holding
Funds holding: 88 → 94 (+6)
6.68% more ownership
Funds ownership: 80.48% → 87.16% (+6.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$11.1M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$10.7M |
| 3 |
Millennium Management
New York
|
+$6.72M |
| 4 |
DCM
Difesa Capital Management
New York
|
+$3.08M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$2.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$9.06M |
| 2 |
HI
HBK Investments
Dallas,
Texas
|
-$7.5M |
| 3 |
Parallax Volatility Advisers
San Francisco,
California
|
-$3.52M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.94M |
| 5 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$2.94M |
COCH Hedge Fund Activity: Q3 2022 in Review
94 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q3 2022, worth a combined $361M — up 7.8% from $335M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new COCH positions and 9 closed out — a net gain of 6 holders — while 23 added to existing stakes and 7 trimmed.
The largest buyer was BNP Paribas Financial Markets, opening a new position worth an estimated $11.1M. The largest seller was Goldman Sachs, cutting an estimated $9.06M.
- 94 institutional investors held Envoy Medical (COCH) as of Q3 2022, up from 88 in Q2 2022.
- Funds reported $361M of Envoy Medical stock for Q3 2022, up 7.8% quarter-over-quarter.
- 15 funds opened new Envoy Medical positions in Q3 2022 and 9 closed out, a net change of +6 holders.
- The largest Envoy Medical buyer in Q3 2022 was BNP Paribas Financial Markets, an estimated $11.1M added.
- The largest Envoy Medical seller in Q3 2022 was Goldman Sachs, an estimated $9.06M sold.
Based on aggregated 13F filings for Q3 2022.